Osteosarcoma, an aggressive primary bone cancer, predominantly affects children, adolescents, and young adults. Despite advancements in treatment over the past few decades, including neoadjuvant chemotherapy and surgical resection, the prognosis for patients with metastatic or recurrent disease remains unfortunately poor. This underscores the critical need for deeper insights into osteosarcoma's…
Sign in to your account